TrialCardiovascular diabetology2026

SGLT2 inhibitors reduce the salt sensitivity of blood pressure in type 2 diabetes via enhanced postprandial natriuresis.

Martina Chiriacò et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.